MET exon 14 skipping is an alteration in the MET gene that can lead to MET dysregulation, which occurs in 1–4% of East Asian patients with NSCLC (5–7) and 3–4% of Western patients (8–10). This evidence concerns the gene MET and non-small cell lung carcinoma.